Open9.460 | Close9.960 |
Vol / Avg.235.431K / 168.621K | Mkt Cap180.799M |
Day Range9.460 - 10.030 | 52 Wk Range6.920 - 21.200 |
OptimizeRx Stock (NASDAQ: OPRX) stock price, news, charts, stock research, profile.
Open9.460 | Close9.960 |
Vol / Avg.235.431K / 168.621K | Mkt Cap180.799M |
Day Range9.460 - 10.030 | 52 Wk Range6.920 - 21.200 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.000 | 0.090 | 0.0900 | ||||
REV | 15.010M | 16.331M | 1.321M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.020 | -0.010 | 0.0100 | ||||
REV | 14.810M | 13.818M | -992.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-15 | RBC Capital | Sean Dodge | Maintains | OutperformOutperform | Lowers | 18.00 | 14.00 |
2023-08-15 | Lake Street | Eric Martinuzzi | Maintains | BuyBuy | Lowers | 18.00 | 13.00 |
2023-08-15 | Roth MKM | Richard Baldry | Maintains | BuyBuy | Lowers | 31.00 | 20.00 |
2023-08-15 | B. Riley Securities | Neil Chatterji | Maintains | BuyBuy | Lowers | 28.00 | 18.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
OPRX | OptimizeRx | 4.73% | 180.8M |
MPLN | MultiPlan | 2.31% | 863.8M |
GDRX | GoodRx Holdings | 6.34% | 2.6B |
DH | Definitive Healthcare | 3.27% | 991.1M |
VEEV | Veeva Sys | 2.09% | 28.6B |
You can purchase shares of OptimizeRx (NASDAQ: OPRX) through any online brokerage.
Other companies in OptimizeRx’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH), Veeva Sys (NYSE:VEEV) and Health Catalyst (NASDAQ:HCAT).
The latest price target for OptimizeRx (NASDAQ: OPRX) was reported by RBC Capital on Tuesday, August 15, 2023. The analyst firm set a price target for 14.00 expecting OPRX to rise to within 12 months (a possible 40.56% upside). 7 analyst firms have reported ratings in the last year.
The stock price for OptimizeRx (NASDAQ: OPRX) is $9.96 last updated December 1, 2023 at 9:00 PM UTC.
There is no dividend information for OptimizeRx.
OptimizeRx’s Q3 earnings are confirmed for Monday, November 6, 2023.
There is no upcoming split for OptimizeRx.
OptimizeRx is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.